Economic burden of pneumococcal disease in children in Liguria, Italy-Reference-Cited by-同舟云学术

Economic burden of pneumococcal disease in children in Liguria, Italy

Published:2022-06-13 Issue:5 Volume:18 Page:
ISSN:2164-5515
Container-title:Human Vaccines & Immunotherapeutics
language:en
Short-container-title:Human Vaccines & Immunotherapeutics

Author:

Amicizia Daniela¹²^ORCID,Astengo Matteo¹,Paganino Chiara¹,Piazza Maria Francesca¹^ORCID,Sticchi Camilla¹,Orsi Andrea²^ORCID,Varlese Federica¹,Hu Tianyan³,Petigara Tanaz³,Senese Francesca⁴,Prandi Gian Marco⁴,Icardi Giancarlo²^ORCID,Ansaldi Filippo¹²

Affiliation:

1. Planning, Epidemiology and Prevention Unit, Regional Health Agency of Liguria (ALiSa), Genoa, Italy

2. Department of Health Sciences (DiSSal), University of Genoa, Genoa, Italy

3. Center for Observational and Real World Evidence (CORE), Merck & Co, Inc, Rahway, NJ, USA

4. MSD Italy, Rome, Italy

Funder

Merck Sharp & Dohme LLC

Publisher

Informa UK Limited

Subject

Pharmacology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/21645515.2022.2082205

Reference37 articles.

1. Centers for Disease Control and Prevention. Pneumococcal disease - Types of infection. [accessed 2021 Sep 22]. https://www.cdc.gov/pneumococcal/about/infection-types.html.

2. International Vaccine Access Center (IVAC). Johns Hopkins Bloomberg School of Public Health. VIEW-hub report: global vaccine introduction and implementation. [accessed 2021 Sep 22]. https://view-hub.org/sites/default/files/2020-08/VIEW-hub_Report_Jun2020_1.pdf.

3. Changes in the pneumococcal disease-related hospitalisations in Spain after the replacement of 7-valent by 13-valent conjugate vaccine

4. European Centre for Disease Prevention and Control. Invasive pneumococcal disease - annual epidemiological report for 2017. [accessed 2019 Oct 4]. https://www.ecdc.europa.eu/sites/default/files/documents/AER_for_2017-invasive-pneumococcal-disease.pdf.

5. Burden of Streptococcus pneumoniae and Haemophilus influenzae type b disease in children in the era of conjugate vaccines: global, regional, and national estimates for 2000–15

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cost savings of pneumococcal vaccination in children with nephrotic syndrome in a low-middle-income country;Pediatric Nephrology;2024-04-30

2. Clinical and economic burden of acute otitis media caused by Streptococcus pneumoniae in European children, after widespread use of PCVs–A systematic literature review of published evidence;PLOS ONE;2024-04-02

3. RIO-kinase 2 is essential for hematopoiesis;PLOS ONE;2024-04-02

4. Healthcare resource utilisation and cost of pneumococcal disease from 2003 to 2019 in children ≤17 years in England;PLOS ONE;2023-04-05

5. Healthcare resource utilization and cost of pneumococcal disease in children in Germany, 2014–2019: a retrospective cohort study;Pneumonia;2023-03-25